Advertisement
Screener

Eledon Pharmaceuticals, Inc. (ELDN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Eledon Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Eledon Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $62.34M went out.
  • Fiscal year ended 2025-12-31: from investing, $10.79M came in.
  • Fiscal year ended 2025-12-31: from financing, $53.81M came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.26M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$62.34M$10.79M$230.00K$53.58M*$2.26M
2024-12-31-$47.27M-$70.31M$215.00K$133.31M*$15.94M
2023-12-31-$39.53M-$45.29M$33.02M*-$51.80M
2022-12-31-$28.42M-$28.42M
2021-12-31-$28.91M$1.00K-$29.36M
2020-12-31-$15.21M$11.04M$9.00M$100.58M*$105.40M
2019-12-31-$13.86M$9.68M-$4.18M
2018-12-31-$11.89M$7.49M-$4.33M
2017-12-31-$14.94M$23.26M$4.75M$3.12M*$16.19M
2016-12-31-$4.92M$1.00K$37.00K$2.89M*-$1.99M
2015-12-31-$41.24M-$40.51M$464.00K-$81.23M
2014-12-31-$21.12M-$175.00K$16.00K$94.78M*$73.50M
2013-12-31-$15.48M-$53.00K$215.00K$35.38M*$20.06M
2012-12-31-$9.33M-$8.00K$4.00K$18.77M*$9.44M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$22.68M*$23.24M*
2026-03-31-$22.61M$5.96M-$16.66M
2025-12-31-$14.09M*-$20.46M*$115.00K*$53.58M*
2025-09-30-$14.48M*$12.40M*$0.00*
2025-06-30-$17.71M*$14.96M*$0.00*
2025-03-31-$16.06M$3.89M$115.00K-$12.05M
2024-12-31-$18.99M*-$47.38M*$80.17M*
2024-09-30-$11.77M*-$12.80M*$5.28M*
2024-06-30-$7.77M*-$19.91M*$48.07M*
2024-03-31-$8.74M$9.78M$1.04M
2023-12-31-$9.13M*$10.08M*
2023-09-30-$12.25M*-$25.03M*
2023-06-30-$8.22M*
2023-03-31-$9.92M-$9.92M
2022-12-31-$9.48M*
2022-09-30-$4.57M*
2022-06-30-$6.22M*
2022-03-31-$8.16M-$8.16M
2021-12-31-$9.21M*$0.00*
2021-09-30-$7.09M*
2021-06-30-$7.45M*
2021-03-31-$5.17M-$5.62M
2020-12-31-$9.43M*$0.00*$9.16M*
2020-09-30-$561.00K*$95.23M*
2020-06-30-$3.02M*
2020-03-31-$2.20M$5.19M*$2.99M
2019-12-31-$2.02M*$0.00*
2019-09-30-$2.89M*$0.00*
2019-06-30-$4.92M*$9.57M*
2019-03-31-$4.02M$107.00K-$3.92M
2018-12-31-$3.35M*$1.00K*
2018-09-30-$2.94M*-$1.00K*
2018-06-30-$3.33M*$0.00*
2018-03-31-$2.27M$7.49M$5.22M
2017-12-31-$2.61M*$0.00*$750.00K*
2017-09-30-$3.42M*$0.00*$0.00*
2017-06-30-$8.03M*$18.93M*$6.72M*
2017-03-31-$882.00K$4.33M-$482.00K
2016-12-31-$1.28M*$13.00K*$0.00*$4.59M*
2016-09-30-$1.48M*-$2.00K*$0.00*$2.89M*$6.47M*
2016-06-30$7.58M*$7.00K*$0.00*-$2.15M*
2016-03-31-$9.74M-$17.00K$37.00K-$9.72M
2015-12-31-$8.88M*-$316.00K*$48.00K*-$9.14M*
2015-09-30-$10.25M*-$15.85M*$188.00K*-$25.92M*
2015-06-30-$11.01M*-$24.30M*$207.00K*-$35.08M*
2015-03-31-$11.10M-$45.00K$21.00K-$11.09M
2014-12-31-$6.46M*$0.00*$4.00K*$6.25M*-$208.00K*
2014-09-30-$4.46M*-$157.00K*$0.00*$88.94M*$84.31M*
2014-06-30-$5.42M*-$6.00K*$8.00K*-$5.86M*
2014-03-31-$4.78M-$12.00K$4.00K-$4.74M
2013-12-31-$6.82M*-$4.00K*$0.00*$15.46M*$8.64M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Nkarta, Inc. (NKTX)United States$0.205B-1.73
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12